SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-07-002974
Filing Date
2007-03-01
Accepted
2007-03-01 06:02:38
Documents
9
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K y31069e10vk.htm 10-K 1412212
2 EX-10.53: LETTER AGREEMENT y31069exv10w53.htm EX-10.53 9301
3 EX-10.61: EXCLUSIVE LICENSE AGREEMENT y31069exv10w61.htm EX-10.61 265336
4 EX-21: SUBSIDIARIES y31069exv21.htm EX-21 1032
5 EX-23: CONSENT OF KPMG LLP y31069exv23.htm EX-23 2985
6 EX-31.1: CERTIFICATION y31069exv31w1.htm EX-31.1 7688
7 EX-31.2: CERTIFICATION y31069exv31w2.htm EX-31.2 8086
8 EX-32.1: CERTIFICATION y31069exv32w1.htm EX-32.1 3978
9 EX-32.2: CERTIFICATION y31069exv32w2.htm EX-32.2 4084
  Complete submission text file 0000950123-07-002974.txt   1716190
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15190 | Film No.: 07660402
SIC: 2835 In Vitro & In Vivo Diagnostic Substances